Allurion Technologies: Study Results Cause Rally, But I'm Awaiting 2024 FDA Catalyst [Seeking Alpha]
Allurion Technologies, Inc. (ALUR)
Company Research
Source: Seeking Alpha
The company currently sells the balloon to Europe, but US potential is still limited by awaiting FDA approval anticipated in late 2024. FDA approval is Allurion's major positive catalyst. The current balance sheet is weak even after a debt refinancing, making an equity raise quite likely as a year's worth of cash churn remains on Allurion's balance sheet. The valuation is very volatile, as successful product scaling could multiply the stock price, but a failed FDA approval could make the stock nearly worthless. Allurion Technologies Inc. NYSE: ALUR ) is developing a weight loss program, Allurion Program, that includes a swallowable gastric balloon and a monitoring program that reduce body fat as the balloon takes up space in the stomach, reducing appetite. On the company's website, Allurion claims Recommended For You
Show less
Read more
Impact Snapshot
Event Time:
ALUR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALUR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALUR alerts
High impacting Allurion Technologies, Inc. news events
Weekly update
A roundup of the hottest topics
ALUR
News
- Allurion Technologies Inc. (NYSE: ALUR) was upgraded by analysts at Roth Capital to a "strong-buy" rating.MarketBeat
- Allurion Technologies Inc. (NYSE: ALUR) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $2.00 price target on the stock.MarketBeat
- Allurion Receives Continued Listing Standards Notice from NYSE [Yahoo! Finance]Yahoo! Finance
- Allurion Receives Continued Listing Standards Notice from NYSEBusiness Wire
- Allurion Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from ObesityBusiness Wire
ALUR
Earnings
- 3/21/24 - Beat
ALUR
Sec Filings
- 9/12/24 - Form 3
- 9/6/24 - Form 424B3
- 9/6/24 - Form 424B3
- ALUR's page on the SEC website